Therapeutic of respiratory manifestations at the early phase of acute myeloid leukaemia;Prise en charge thérapeutique des manifestations pulmonaires à la phase aiguë des leucémies aiguës myéloblastiques

Revue des Maladies Respiratoires

Volumn 29, Issue 6, 2012, Pages 743-755

  Vincent, F ^a   Hospital, M A ^b   Lemiale, V ^b   Bruneel, F ^c   Darmon, M ^d   Gonzalez, F ^a   Kouatchet, A ^e   Mokart, D ^f   Pene F ^g   Rabbat, A ^h   Cohen, Y ^a   Azoulay, E ^b  

^a AVICENNE HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c CENTRE HOSPITALIER DE VERSAILLES   (France)

^d UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f INSTITUT PAOLI CALMETTES   (France)

^g Hôpital Cochin ^*  (France)

^h HÔTEL DIEU   (France)

Author keywords

Acute myeloid leukaemia; Leukostasis; Lung; Therapeutics; Tumor Lysis Syndrome

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; CANCER PATIENT; CLINICAL FEATURE; CONSENSUS; DISEASE COURSE; DISEASE SEVERITY; HUMAN; INTENSIVE CARE UNIT; PATIENT CARE; RESPIRATORY TRACT DISEASE; REVIEW; TUMOR LYSIS SYNDROME;

EID: 84865725286     PISSN: 07618425     EISSN: 17762588     Source Type: Journal    
DOI: 10.1016/j.rmr.2012.04.002     Document Type: Review

References (87)

1. Uzunhan Y Cadranel J, Boissel N, et al. The specific pulmonary manifestations of acute myeloid leukaemia. Rev Mal Respir 2010;27:589-98.
2. Uzunhan Y Cadranel J, Boissel N, et al. Lung involvement in lymphoid and lympho-plasmocytic proliferations (except lymphomas). Rev Mal Respir 2010;27:599-610.
3. Al Ameri A, Koller C, Kantarjian H, et al. Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome. Cancer 2010;116:93-7.
4. Hildebrand Jr FL, Rosenow 3rd EC, Habermann TM, et al. Pulmonary complications of leukemia. Chest 1990;98: 1233-9. (Pubitemid 20381294)
5. Koh TT, Colby TV, Muller NL. Myeloid leukemias and lung involvement. Semin Respir Crit Care Med 2005;26:514-9. (Pubitemid 41552380)
6. Tallman MS, Abutalib SA, Altman JK. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia. Semin Thromb Hemost 2007;33:330-8. (Pubitemid 46878105)
7. Sanz MA. Treatment of acute promyelocytic leukemia. Hematology Am Soc Hematol Educ Program 2006:147-55.
8. Chagnon K, Boissel N, Raffoux E, et al. A new pattern of cytosine-arabinoside-induced lung toxicity. Br J Haematol 2009;147:771-4.
9. Azoulay E, Fieux F, Moreau D, et al. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 2003;167:1329-33. (Pubitemid 36609715)
10. Rowe JM, Lichtman MA. Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia. Blood 1984;63:1230-4. (Pubitemid 14100929)
11. Ozdemir MA, Karakukcu M, Patiroglu T et al. Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia. Acta Haematol 2009;121: 56-62.
12. Porcu P, Cripe LD, Ng EW, et al. Hyperleukocyticleukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma 2000;39:1-18. (Pubitemid 30662024)
13. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol 1985;3:1590-5. (Pubitemid 16199210)
14. Ahmed S, Siddiqui AK, Rossoff L, et al. Pulmonary complications in chronic lymphocytic leukemia. Cancer 2003;98:1912-7. (Pubitemid 37310234)
15. Blum W, Porcu P. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome. Semin Thromb Hemost 2007;33:350-4. (Pubitemid 46878107)
16. Kwaan HC, Huyck T Thromboembolic and bleeding complications in acute leukemia. Expert Rev Hematol 2010;3:719-30.
17. Stucki A, Rivier AS, Gikic M, et al. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 2001;97:2121-9. (Pubitemid 32239095)
18. Paschka P. Core binding factor acute myeloid leukemia. Semin Oncol 2008;35:410-7.
19. Soares FA, Landell GA, Cardoso MC. Pulmonary leukostasis without hyperleukocytosis: a clinicopathologic study of 16 cases. Am J Hematol 1992;40:28-32.
20. Tryka AF, Godleski JJ, Fanta CH. Leukemic cell lysis pneu-monopathy. A complication of treated myeloblastic leukemia. Cancer 1982;50:2763-70. (Pubitemid 13220782)
21. Dombret H, Hunault M, Faucher C, et al. Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils. Cancer 1992;69:1356-61.
22. Andersson BS, Luna MA, Yee C, et al. Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia. Cancer 1990;65:1079-84. (Pubitemid 20072037)
23. Jehn U, Goldel N, Rienmuller R, et al. Non-cardiogenic pulmonary edema complicating intermediate high-dose Ara C treatment for relapsed acute leukemia. Med Oncol Tumor Phar-macother 1988;5:41-7.
24. Forghieri F, Luppi M, Morselli M, et al. Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. Haematologica 2007;92:e85-90.
25. Wurthner JU, Kohler G, Behringer D, et al. Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis: a clinicopathologic report of four cases. Cancer 1999;85:368-74. (Pubitemid 29051291)
26. Wan TS, Yip SF, Yeung YM, et al. Fatal diffuse alveolar damage complicating acute myeloid leukemia with abnormal eosinophils and trisomy X. Ann Hematol 2002;81:167-9. (Pubitemid 36067599)
27. Hijiya N, Metzger ML, Pounds S, et al. Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia. Pediatr Blood Cancer 2005;44:63-9. (Pubitemid 39602569)
28. Huizar I, Kavuru MS. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management. Curr Opin Pulm Med 2009;15:491-8.
29. Cordonnier C, Fleury-Feith J, Escudier E, et al. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994;149:788-94. (Pubitemid 24082243)
30. Inaba H, Jenkins JJ, McCarville MB, et al. Pulmonary alveolar proteinosis in pediatric leukemia. Pediatr Blood Cancer 2008;51:66-70. (Pubitemid 351717392)
31. Ishii H, Trapnell BC, Tazawa R, et al. Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest 2009;136:1348-55.
32. Rossi SE, Erasmus JJ, Volpacchio M, et al. "Crazy-paving" pattern at thin-section CT of the lungs: radiologic-pathologic overview. Radiographics 2003;23:1509-19. (Pubitemid 37487527)
33. Maimon N, Heimer D. The crazy-paving pattern on computed tomography. CMAJ 2010;182:1545.
34. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44years. Am J Respir Crit Care Med 2002;166:215-35. (Pubitemid 34765459)
35. Hess CE, Nichols AB, Hunt WB, et al. Pseudohypoxemia secondary to leukemia and thrombocytosis. N Engl J Med 1979;301:361-3. (Pubitemid 10242790)
36. Fox MJ, Brody JS, Weintraub LR. Leukocyte larceny: a cause of spurious hypoxemia. Am J Med 1979;67:742-6. (Pubitemid 10218823)
37. Chillar RK, Belman MJ, Farbstein M. Pseudohypoxemia due to leukemia and thrombocytosis. N Engl J Med 1980;302:584.
38. Lele AV, Mirski MA, Stevens RD. Spurious hypoxemia. Crit Care Med 2005;33:1854-6. (Pubitemid 41153713)
39. Gorski TF, Ajemian M, Hussain E, et al. Correlation of pseudohypoxemia and leukocytosis in chronic lymphocytic leukemia. South Med J 1999;92:817-9. (Pubitemid 29383947)
40. Gartrell K, Rosenstrauch W. Hypoxaemia in patients with hyperleukocytosis: true or spurious, and clinical implications. Leuk Res 1993;17:915-9. (Pubitemid 23330142)
41. Darmon M, Azoulay E. Prognosis of acute monocytic leukemia (French-American-British classification M5). J Clin Oncol 2005;23:1327 [author reply 27-28]. (Pubitemid 46202300)
42. Bierman HR, Marshall GJ, Kelly KH, et al. Leukapheresis in man. III. Hematologic observations in patients with leukemia and myeloid metaplasia. Blood 1963;21:164-82.
43. Hiroto I, Ying F, Stanley P, et al. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer 2008;113:522-9.
44. Vahdat L, Maslak P, Miller Jr WH, et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 1994;84:3843-9.
45. Abla O, Khanani MF, Hitzler JK, et al. Complications of hyperleukocytosis and leukapheresis in pediatric acute leukemias. ASH Annu Meeting Abstr 2004;104:1963.
46. Grund FM, Armitage JO, Burns P. Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia. Arch Intern Med 1977;137:1246-7. (Pubitemid 9067117)
47. Berg J, Vincent PC, Gunz FW. Extreme leucocytosis and prognosis of newly diagnosed patients with acute non-lymphocytic leukaemia. Med J Aust 1979;1:480-2. (Pubitemid 9240867)
48. Quessar AM, Khoubila NR, Ribeiro RCU, et al. Hydroxyurea in the early management of acute myeloid leukemia and hyperleukocytosis. ASH Annu Meeting Abstr 2007;110:4368.
49. Kuo KHM, Callum J, Brandwein J, et al. Management of hyperleukocytosis in acute myelogenous leukemia using hydroxyurea rather than leukopheresis. ASH Annu Meeting Abstr 2006;108:2007.
50. Dohner H, Estey EH, Amadori S. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European leukemia net. Blood 2010;115:453-74.
51. Azoulay E, Canet E, Raffoux E, et al. Dexamethasone in patients with acute lung injury from acute monocytic leukemia. Eur Respir J 2012;39:648-53.
52. Leis JF, Primack SL, Schubach SE, et al. Management of life-threatening pulmonary leukostasis with single agent ima-tinib mesylate during CML myeloid blast crisis. Haematologica 2004;89:ECR30.
53. Ramanujam D, McNicholl F, Furby D, et al. Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma. Leuk Lymphoma 2009;50:1721-2.
54. Pinheiro RF, Santiago SP, Lopes A, et al. Pulmonary leukostasis mimicking tuberculosis in endemic area. Leuk Res 2010;34:e128-9.
55. Darmon M, Guichard I, Vincent F, et al. Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leuk Lymphoma 2010;51:221-7.
56. Coiffier B, Altman A, Pui CH, et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008;26: 2767-78.
57. Brochard L, Abroug F Brenner M, et al. An official ATS/ERS/ESICM/SCCM/ SRLF statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med 2010;181:1128-55.
58. Montesinos P, Lorenzo I, Martin G, et al. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica 2008;93:67-74. (Pubitemid 351156153)
59. Sumida Y, Nakamura K, Kanayama K, et al. Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy. Cytotherapy 2008;10:698-710.
60. Cairo MS, Coiffier B, Reiter A, et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 2010;149:578-86.
61. Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004;127:3-11. (Pubitemid 39331101)
62. Conger JD, Falk SA. Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. J Clin Invest 1977;59:786-93. (Pubitemid 8096330)
63. Goldman SC. Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies. Expert Rev Anticancer Ther 2003;3:429-33. (Pubitemid 37009842)
64. Darmon M, Guichard I, Vincent F. Rasburicase and tumor lysis syndrome: lower dosage, consideration of indications, and hyperhydration. J Clin Oncol 2011;20:e67-8 [author reply e69].
65. Hebert LA, Lemann Jr J, Petersen JR, et al. Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest 1966;45:1886-94.
66. Boles JM, Dutel JL, Briere J, et al. Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia. Cancer 1984;53:2425-9. (Pubitemid 14102482)
67. Davidson MB, Thakkar S, Hix JK, et al. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 2004;116:546-54. (Pubitemid 38452647)
68. Darmon M, Thiery G, Ciroldi M, et al. Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med 2007;33:765-72. (Pubitemid 46675318)
69. Benoit DD, Hoste EA. Acute kidney injury in critically ill patients with cancer. Crit Care Clin 2010;26:151-79.
70. Crawford J, Althaus B, Armitage J. Myeloid growth factors. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2007;5:188-202. (Pubitemid 46423058)
71. Azoulay E, Fieux F, Moreau D. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 2003;167:1329-33. (Pubitemid 36609715)
72. Luisetti M, Kadija Z, Mariani F, et al. Therapy options in pulmonary alveolar proteinosis. Ther Adv Respir Dis 2010;4:239-48.
73. Sergeeva A, Ono Y Rios R, et al. High titer autoantibodies to GM-CSF in patients with AML, CML and MDS are associated with active disease. Leukemia 2008;22:783-90. (Pubitemid 351552627)
74. Numata A, Matsuishi E, Koyanagi K, et al. Successful therapy with whole-lung lavage and autologous peripheral blood stem cell transplantation for pulmonary alveolar proteinosis complicating acute myelogenous leukemia. Am J Hematol 2006;81:107-9. (Pubitemid 43208598)
75. Pamuk GE, Turgut B, Vural O, et al. Pulmonary alveolar proteinosis in a patient with acute lymphoid leukemia: regression after G-CSF therapy. Leuk Lymphoma 2003;44: 871-4. (Pubitemid 36410996)
76. Lengliné E, Raffoux E, Lemiale V, et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 2012. Feb 13. [Epub ahead of print].
77. Darmon M, Thiery G, Ciroldi M, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 2005;33:2488-93. (Pubitemid 41682099)
78. Benoit DD, Depuydt PO, Vandewoude KH, et al. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med 2006;32:93-9. (Pubitemid 43039382)
79. Azoulay E, Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 2006;32:3-5. (Pubitemid 43039368)
80. Darmon M, Azoulay E. Critical care management of cancer patients: cause for optimism and need for objectivity. Curr Opin Oncol 2009;21:318-26.
81. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33: 451-8.
82. Cuttner J, Holland JF, Norton L, et al. Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia. Med Pediatr Oncol 1983;11:76-8. (Pubitemid 13091362)
83. Porcu P, Danielson CF, Orazi A, et al. Therapeutic leukapheresis in hyperleucocyticleukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol 1997;98:433-6. (Pubitemid 27345121)
84. Giles FJ, Shen Y Kantarjian HM, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma 2001;42:67-73. (Pubitemid 32700923)
85. Inaba H, Fan Y, Pounds S, et al. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer 2008;113:522-9.
86. Myers TJ, Cole SR, Klatsky AU, et al. Respiratory failure due to pulmonary leukostasis following chemotherapy of acute non-lymphocytic leukemia. Cancer 1983;51:1808-13. (Pubitemid 13093947)
87. Lester WA, Hull DR, Fegan CD, et al. Respiratory failure during induction chemotherapy for acute myelomonocytic leukaemia (FAB M4Eo) with ara-C and all-trans retinoic acid. Br J Haematol 2000;109:847-50. (Pubitemid 30609767)